Journal article
Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation
E Wong, J Davis, R Koldej, J Szer, A Grigg, D Ritchie
Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2020
Grants
Funding Acknowledgements
The work described in this manuscript pertains to a clinical trial which was funded by Bristol-Myers Squibb.